Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01742988
Title Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Curis, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
University of Chicago Medicine Chicago Illinois 60637 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field